psoriasis

April Armstrong, MD, MPH, Dermatology Week 2022
Conference Coverage
Novel Topical PDE-4 Inhibitors For Plaque Psoriasis, Atopic Dermatitis, and Seborrheic Dermatitis
05/12/2022
On the first day of Dermatology Week 2022, April Armstrong, MD, MPH, opened her session by noting, “There are common unmet needs in inflammatory skin diseases and that created opportunities for new well tolerated and effective topical...
On the first day of Dermatology Week 2022, April Armstrong, MD, MPH, opened her session by noting, “There are common unmet needs in inflammatory skin diseases and that created opportunities for new well tolerated and effective topical...
On the first day of Dermatology...
05/12/2022
The Dermatologist
Psoriasis_COVID-19_COVID
Conference Coverage
The Impact of IMID Treatment on COVID-19 Risk
04/21/2022
Joel M. Gelfand, MD, MSCE, kicked off the session by saying, “In spring 2020, COVID toes were reported to occur 1 to 4 weeks post onset of COVID-19 symptoms.”
Joel M. Gelfand, MD, MSCE, kicked off the session by saying, “In spring 2020, COVID toes were reported to occur 1 to 4 weeks post onset of COVID-19 symptoms.”
Joel M. Gelfand, MD, MSCE,...
04/21/2022
The Dermatologist
News
Body Composition Associated with Liver Fibrosis Development in Patients With Psoriasis
11/11/2021
For patients with psoriasis, body composition is associated with nonalcoholic hepatic fibrosis in both genders, but anthropometric data should be assessed differently in men and women.
For patients with psoriasis, body composition is associated with nonalcoholic hepatic fibrosis in both genders, but anthropometric data should be assessed differently in men and women.
For patients with psoriasis,...
11/11/2021
The Dermatologist
News
PsA Risk Highest in Patients With Severe Psoriasis
09/22/2021
A recent study published in Journal of the American Academy of Dermatology concluded that the risk of psoriatic arthritis (PsA) increases with psoriasis severity, with patients with severe psoriasis having the highest risk of PsA. Merola...
A recent study published in Journal of the American Academy of Dermatology concluded that the risk of psoriatic arthritis (PsA) increases with psoriasis severity, with patients with severe psoriasis having the highest risk of PsA. Merola...
A recent study published in...
09/22/2021
The Dermatologist
psoriasis
Poll
Factors When Starting a New Biologic for Psoriasis
06/06/2021
06/06/2021
The Dermatologist
DERM - Psoriasis MRC
FDA Alerts
New FDA Approval to Treat Moderate to Severe Pediatric Psoriasis
06/01/2021
The FDA announced approval of secukinumab, an IL-17 inhibitor, for the treatment of moderate to severe plaque psoriasis in patients aged 6 years and older. The approved dosing is 75 mg or 150 mg, dependent on the child’s weight at dosing...
The FDA announced approval of secukinumab, an IL-17 inhibitor, for the treatment of moderate to severe plaque psoriasis in patients aged 6 years and older. The approved dosing is 75 mg or 150 mg, dependent on the child’s weight at dosing...
The FDA announced approval of...
06/01/2021
The Dermatologist
Partner Approved
The Psoriasis and Comorbidity Series: Inflammatory Bowel Disease
12/14/2020
Psoriasis has a known association with inflammatory bowel disease, including Crohn disease and ulcerative colitis. Dermatologists should keep the association in mind when treating their patients with psoriasis.
Psoriasis has a known association with inflammatory bowel disease, including Crohn disease and ulcerative colitis. Dermatologists should keep the association in mind when treating their patients with psoriasis.
Psoriasis has a known...
12/14/2020
The Dermatologist
Online Exclusive
Can Halobetasol Have An Impact For Treating Psoriasis?
12/29/2019
Psoriasis can commonly appear on the lower extremities but much of the literature does not address this condition in this anatomic area. Accordingly, this author shares three recent studies and their results regarding a novel formulization of...
Psoriasis can commonly appear on the lower extremities but much of the literature does not address this condition in this anatomic area. Accordingly, this author shares three recent studies and their results regarding a novel formulization of...
Psoriasis can commonly appear on...
12/29/2019
Podiatry Today
Feature
Current And Emerging Modalities For Psoriasis
10/08/2018
Palmoplantar psoriasis can be a particularly devastating condition, given the condition’s negative effect on quality of life. These authors provide a stepwise guide to therapy, progressing from topical steroids to phototherapy to biologics...
Palmoplantar psoriasis can be a particularly devastating condition, given the condition’s negative effect on quality of life. These authors provide a stepwise guide to therapy, progressing from topical steroids to phototherapy to biologics...
Palmoplantar psoriasis can be a...
10/08/2018
Podiatry Today
Case Report and Brief Review
Efficacy of Natural Honey Versus Fluticasone Propionate in Mild Psoriasis: A Case Study
09/28/2017
09/28/2017
Wounds

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use